Total Funding
40
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 40 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Celixir is a unique technology platform drives in-house discovery and manufacturing.
Ajan Reginald: Co-Founder & CEOPast Role: Roche, Head of Emerging Technologies
About the Company
Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchers
to discover breakthrough medicines that aim to change the standard of medical care for patients.